Drawing for NAUTILUS BIOTECH

USPTO serial 76174900

NAUTILUS BIOTECH

Reviewed by CopyMark Law Group

Reg. 2697075Status 710
Filing date
Status date
Registration date
Mar 18, 2003
Examiner
BUSH, KAREN K
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NAUTILUS BIOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Beth M. Goldman

Beth M. Goldman Orrick, Herrington & Sutcliffe LLP4 Park PlazaSuite 1600Irvine, CA 92614-2558

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific or medical research use, namely, gene transfer vectors and recombinant virusesSECTION 8 - CANCELLED—
005Pharmaceutical preparations for the treatment of diseases, namely, infectious disease, allergies, microbial disease, pregnancy-related disease, bacterial disease, heart disease, viral disease, histological disease, genetic disease, blood-related disease, fungal disease, adrenal disease, cancer, liver disease, autoimmune disease, growth disorder, and diabetes, using gene therapy; clinical, medical reagents for use in gene therapy for the treatment of diseases; clinical, medical reagents, namely, gene transfer vectors and recombinant virusesSECTION 8 - CANCELLED—
042Medical research, namely, the evaluation and selection of products fit for the prevention and treatment of diseases by gene therapy and the evaluation of viral vectors; scientific research, namely, the evaluation and selection of products fit for the prevention and treatment of diseases by gene therapy and the evaluation of viral vectors; scientific research and testing, namely, the identification of genes and vector screeningSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2009C8..CANCELLED SEC. 8 (6-YR)—
Dec 18, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 20, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 15, 2008CFITCASE FILE IN TICRS—
Mar 18, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 24, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2002TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 4, 2002NPUBNOTICE OF PUBLICATION—
Oct 2, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2002DOCKASSIGNED TO EXAMINER—
Aug 16, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 2002MAILPAPER RECEIVED—
Jul 24, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 3, 2002DOCKASSIGNED TO EXAMINER—
May 15, 2002CNEAEXAMINERS AMENDMENT MAILED—
May 14, 20021.BDSec. 1(B) CLAIM DELETED—
Apr 22, 2002DOCKASSIGNED TO EXAMINER—
Apr 22, 2002DOCKASSIGNED TO EXAMINER—
Sep 28, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2001UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Apr 6, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance